Foley partner T.J. Ferrante, vice chair of the firm’s Health Care Practice Group, is speaking in Spruce Health’s webinar titled “U.S. Federal and State Telehealth Law & Policy—2024 & Beyond.” The presentation will examine the current regulatory landscape as it relates to digital health.
The webinar will cover:
- The current regulatory landscape as it relates to digital health,
- The key considerations when using telemedicine to prescribe controlled substances under U.S., Drug Enforcement Administration rules,
- New opportunities for remote patient monitoring services, and
- What you can expect for the remainder of 2024.
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.